BOULDER, Colo., July 27, 2015 /PRNewswire/ -- Array
BioPharma Inc. (Nasdaq: ARRY) will report financial results
for the fourth quarter and full year of fiscal 2015 and hold a
conference call to discuss those results on Monday, August 3, 2015. Ron Squarer, Chief
Executive Officer will lead the call.
|
Date:
|
Monday, August 3,
2015
|
|
Time:
|
9:00 a.m. Eastern
Time
|
|
Toll-Free:
|
(844)
464-3927
|
|
Toll:
|
(765)
507-2598
|
|
Pass
Code:
|
68380312
|
|
Webcast, including
Replay and Conference Call Slides:
|
|
http://edge.media-server.com/m/p/999aon7i/lan/en
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Six registration studies are
currently advancing. These programs include three cancer drugs,
binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 /
wholly-owned) and selumetinib (AstraZeneca). For more information
on Array, please go to www.arraybiopharma.com.
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
(303)
386-1193
|
|
thaugeto@arraybiopharma.com
|
Logo -
http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-report-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2015-on-august-3-2015-300119132.html
SOURCE Array BioPharma Inc.